This disclosure relates to new heterocyclic compounds that may be used to modulate a histamine receptor in an individual. Pyrido[3,4-b]indoles are described, as are pharmaceutical compositions comprising the compounds and methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
这份披露涉及可用于调节个体组织中
组胺受体的新
杂环化合物。描述了
吡啶并[3,4-b]
吲哚,以及包含这些化合物的药物组合物和使用这些化合物进行各种治疗应用的方法,包括治疗认知障碍、精神障碍、神经递质介导的障碍和/或神经障碍。